163 related articles for article (PubMed ID: 6399953)
1. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
Peters D
Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.
Fischer-Rasmussen W
Scand J Urol Nephrol Suppl; 1984; 87():35-47. PubMed ID: 6443541
[TBL] [Abstract][Full Text] [Related]
3. A controlled, double-blind, cross-over study of terodiline in motor urge incontinence.
Lukkarinen O; Gröhn P; Wilén-Rosenqvist G; Juusela H; Sotarauta M; Lehtonen T
Ann Chir Gynaecol; 1987; 76(2):128-32. PubMed ID: 3304118
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind trial of terodiline in the treatment of urge incontinence in women.
Norton P; Karram M; Wall LL; Rosenzweig B; Benson JT; Fantl JA
Obstet Gynecol; 1994 Sep; 84(3):386-91. PubMed ID: 8058236
[TBL] [Abstract][Full Text] [Related]
5. The effect of terodiline on patients with detrusor instability.
Macfarlane JR; Tolley DA
Scand J Urol Nephrol Suppl; 1984; 87():51-4. PubMed ID: 6399954
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
[TBL] [Abstract][Full Text] [Related]
7. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
Sole GM; Arkell DG
Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
[TBL] [Abstract][Full Text] [Related]
8. Terodiline treatment of detrusor hyperreflexia in sclerosis multiplex.
Jensen D
J Oslo City Hosp; 1989; 39(6-7):67-73. PubMed ID: 2674379
[TBL] [Abstract][Full Text] [Related]
9. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Wagg A; Wyndaele JJ; Sieber P
Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
[TBL] [Abstract][Full Text] [Related]
12. Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study.
Gerstenberg TC; Klarskov P; Ramirez D; Hald T
Br J Urol; 1986 Apr; 58(2):129-33. PubMed ID: 3516296
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effects of terodiline hydrochloride for urinary frequency and sense of residual urine].
Fujiwara E; Nakano H; Nihira H; Kitano T; Ukai R; Masu C; Onishi Y; Kodama M; Hatachi K; Matsuki A
Hinyokika Kiyo; 1988 Apr; 34(4):733-8. PubMed ID: 3400553
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
Yoneyama T; Ogawa A; Fukui J; Wajiki M; Tomita Y; Igawa Y; Yanagisawa A; Uchiyama S; Watanabe K; Aida Y
Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
[TBL] [Abstract][Full Text] [Related]
15. [Terodiline in the treatment of stress incontinence in women].
Feyereisl J; Hänggi W; Dreher E
Schweiz Rundsch Med Prax; 1990 Apr; 79(14):420-2. PubMed ID: 2343228
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
Sugiyama T; Kiwamoto H; Uchida A; Nagai N; Park YC; Kurita T; Ikegami M; Nakanishi A; Kawamura M; Umekawa T
Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
[TBL] [Abstract][Full Text] [Related]
17. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of long-term administration of terodiline hydrochloride for the treatment of patients with pollakisuria and incontinence].
Tsujimoto Y; Fujisue H; Shima H; Ikoma F; Sakurai T; Sato Y; Tokizane M; Akiyama K; Kato S; Nakachi K
Hinyokika Kiyo; 1988 Apr; 34(4):724-32. PubMed ID: 3400552
[TBL] [Abstract][Full Text] [Related]
19. Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function.
Klarskov P; Gerstenberg TC; Hald T
Scand J Urol Nephrol; 1986; 20(1):41-6. PubMed ID: 3704568
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of terodiline hydrochloride in patients with urinary frequency or incontinence].
Yasuno H; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Kataoka N; Matsushita M; Inaba Y; Umezu K; Yamashita M
Hinyokika Kiyo; 1991 Apr; 37(4):431-9. PubMed ID: 1892003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
